Want to see ACXP full AI Analyst Report?
Ibezapolstat
Clostridium Difficile Infection Recurrence
Phase II
Recruiting
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Mar 24, 2026
―
Vancomycin, Ibezapolstat
Clostridium Difficile Infection
Phase II
Completed
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection
Jan 23, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Acurx Pharmaceuticals (ACXP) have in its pipeline
ACXP is currently developing the following drugs: Ibezapolstat, Vancomycin, Ibezapolstat. These drug candidates are in various stages of clinical development as the company works toward FDA approval.